These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 16640560)

  • 1. A unique binding epitope for salvinorin A, a non-nitrogenous kappa opioid receptor agonist.
    Kane BE; Nieto MJ; McCurdy CR; Ferguson DM
    FEBS J; 2006 May; 273(9):1966-74. PubMed ID: 16640560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toward a structure-based model of salvinorin A recognition of the kappa-opioid receptor.
    Kane BE; McCurdy CR; Ferguson DM
    J Med Chem; 2008 Mar; 51(6):1824-30. PubMed ID: 18293909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential helical orientations among related G protein-coupled receptors provide a novel mechanism for selectivity. Studies with salvinorin A and the kappa-opioid receptor.
    Vortherms TA; Mosier PD; Westkaemper RB; Roth BL
    J Biol Chem; 2007 Feb; 282(5):3146-56. PubMed ID: 17121830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salvinorin A, an active component of the hallucinogenic sage salvia divinorum is a highly efficacious kappa-opioid receptor agonist: structural and functional considerations.
    Chavkin C; Sud S; Jin W; Stewart J; Zjawiony JK; Siebert DJ; Toth BA; Hufeisen SJ; Roth BL
    J Pharmacol Exp Ther; 2004 Mar; 308(3):1197-203. PubMed ID: 14718611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of the molecular mechanisms by which the diterpenoid salvinorin A binds to kappa-opioid receptors.
    Yan F; Mosier PD; Westkaemper RB; Stewart J; Zjawiony JK; Vortherms TA; Sheffler DJ; Roth BL
    Biochemistry; 2005 Jun; 44(24):8643-51. PubMed ID: 15952771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist.
    Roth BL; Baner K; Westkaemper R; Siebert D; Rice KC; Steinberg S; Ernsberger P; Rothman RB
    Proc Natl Acad Sci U S A; 2002 Sep; 99(18):11934-9. PubMed ID: 12192085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of the selectivity of oxymorphone- and naltrexone-derived ligands via site-directed mutagenesis of opioid receptors: exploring the "address" recognition locus.
    Metzger TG; Paterlini MG; Ferguson DM; Portoghese PS
    J Med Chem; 2001 Mar; 44(6):857-62. PubMed ID: 11300867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kappa-opioid receptor-mediated effects of the plant-derived hallucinogen, salvinorin A, on inverted screen performance in the mouse.
    Fantegrossi WE; Kugle KM; Valdes LJ; Koreeda M; Woods JH
    Behav Pharmacol; 2005 Dec; 16(8):627-33. PubMed ID: 16286814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antinociceptive and hypothermic effects of Salvinorin A are abolished in a novel strain of kappa-opioid receptor-1 knockout mice.
    Ansonoff MA; Zhang J; Czyzyk T; Rothman RB; Stewart J; Xu H; Zjwiony J; Siebert DJ; Yang F; Roth BL; Pintar JE
    J Pharmacol Exp Ther; 2006 Aug; 318(2):641-8. PubMed ID: 16672569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoclerodane diterpenes as a novel scaffold for mu opioid receptor ligands.
    Harding WW; Tidgewell K; Byrd N; Cobb H; Dersch CM; Butelman ER; Rothman RB; Prisinzano TE
    J Med Chem; 2005 Jul; 48(15):4765-71. PubMed ID: 16033256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and in vitro pharmacological studies of new C(4)-modified salvinorin A analogues.
    Lee DY; He M; Liu-Chen LY; Wang Y; Li JG; Xu W; Ma Z; Carlezon WA; Cohen B
    Bioorg Med Chem Lett; 2006 Nov; 16(21):5498-502. PubMed ID: 16945525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salvinorin A: allosteric interactions at the mu-opioid receptor.
    Rothman RB; Murphy DL; Xu H; Godin JA; Dersch CM; Partilla JS; Tidgewell K; Schmidt M; Prisinzano TE
    J Pharmacol Exp Ther; 2007 Feb; 320(2):801-10. PubMed ID: 17060492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic studies of neoclerodane diterpenes from Salvia divinorum: semisynthesis of salvinicins A and B and other chemical transformations of salvinorin A.
    Harding WW; Schmidt M; Tidgewell K; Kannan P; Holden KG; Gilmour B; Navarro H; Rothman RB; Prisinzano TE
    J Nat Prod; 2006 Jan; 69(1):107-12. PubMed ID: 16441078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-methylacetamide analog of salvinorin A: a highly potent and selective kappa-opioid receptor agonist with oral efficacy.
    Béguin C; Potter DN; Dinieri JA; Munro TA; Richards MR; Paine TA; Berry L; Zhao Z; Roth BL; Xu W; Liu-Chen LY; Carlezon WA; Cohen BM
    J Pharmacol Exp Ther; 2008 Jan; 324(1):188-95. PubMed ID: 17951511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endomorphin-1 discriminates the mu-opioid receptor from the delta- and kappa-opioid receptors by recognizing the difference in multiple regions.
    Ide S; Sakano K; Seki T; Awamura S; Minami M; Satoh M
    Jpn J Pharmacol; 2000 Aug; 83(4):306-11. PubMed ID: 11001176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and in vitro pharmacological studies of C(4) modified salvinorin A analogues.
    Lee DY; He M; Kondaveti L; Liu-Chen LY; Ma Z; Wang Y; Chen Y; Li JG; Beguin C; Carlezon WA; Cohen B
    Bioorg Med Chem Lett; 2005 Oct; 15(19):4169-73. PubMed ID: 16051487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies toward the pharmacophore of salvinorin A, a potent kappa opioid receptor agonist.
    Munro TA; Rizzacasa MA; Roth BL; Toth BA; Yan F
    J Med Chem; 2005 Jan; 48(2):345-8. PubMed ID: 15658846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salvinorin A: the "magic mint" hallucinogen finds a molecular target in the kappa opioid receptor.
    Sheffler DJ; Roth BL
    Trends Pharmacol Sci; 2003 Mar; 24(3):107-9. PubMed ID: 12628350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic Studies of Neoclerodane Diterpenes from
    Crowley RS; Riley AP; Alder AF; Anderson RJ; Luo D; Kaska S; Maynez P; Kivell BM; Prisinzano TE
    ACS Chem Neurosci; 2020 Jun; 11(12):1781-1790. PubMed ID: 32383854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacology and anti-addiction effects of the novel κ opioid receptor agonist Mesyl Sal B, a potent and long-acting analogue of salvinorin A.
    Simonson B; Morani AS; Ewald AW; Walker L; Kumar N; Simpson D; Miller JH; Prisinzano TE; Kivell BM
    Br J Pharmacol; 2015 Jan; 172(2):515-31. PubMed ID: 24641310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.